What Generex needs to do is give an in-depth discussion of what is going on with their products from Arizona, Excellagen to what is going on with Bintai and China to the uplist.

They need to be as detailed as possible and give timelines on each one this time with what the end results for this year with what is expected throughout the rest of the year.

If they can break it down throughout the rest of the year, what we can expect, I think that will go a long way, but they need to present timelines out for the year, not say this is what we are working on and yada yada yada.

I think breaking down timelines for everything and breaking down those timelines for the rest of the year onward, would allow shareholders and investors to get a perspective of where the company is at and where it is going in the new and long term.